The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

Bayer expands indication of Kerendia in India to include heart failure with preserved and mildly reduced ejection fraction: Our Bureau, Bengaluru Thursday, November 6, 2025, 17:35 ...

India is now the second country to access Bayer's Kerendia, expanding its use to treat heart failure conditions.

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the first patient has ...

An international meta-analysis including nearly 18,000 patients from five clinical trials was coordinated by the CNIC in collaboration with institutions in four other countries ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international ...

In a groundbreaking medical feat, artificial intelligence guided doctors in Bengaluru to safely perform a complex lung biopsy ...

Now, Monash engineers are developing a breakthrough heart pump that could finally offer these patients the mechanical support they've never had.New ...

Heart failure with preserved ejection fraction, or HFpEF, is now the most common form of heart failure. Many people who ...